NDC 52427-661

LOREEV XR

Lorazepam

LOREEV XR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Almatica Pharma Llc. The primary component is Lorazepam.

• Product ID: 52427-661_ec42987a-f232-f189-4641-4f0f823477f3
• NDC: 52427-661
• Product Type: Human Prescription Drug
• Proprietary Name: LOREEV XR
• Generic Name: Lorazepam
• Dosage Form: Capsule, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 2022-03-01
• Marketing Category: NDA /
• Application Number: NDA214826
• Labeler Name: Almatica Pharma LLC
• Substance Name: LORAZEPAM
• Active Ingredient Strength: 2 mg/1
• Pharm Classes: Benzodiazepine [EPC], Benzodiazepines [CS]
• DEA Schedule: CIV
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 52427-661-30

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52427-661-30)

• Marketing Start Date: 2022-03-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "LOREEV XR" or generic name "Lorazepam"

NDC	Brand Name	Generic Name
0187-0063	Ativan	lorazepam
0187-0064	Ativan	lorazepam
0187-0065	Ativan	lorazepam
0054-3532	Lorazepam	Lorazepam
0093-3425	Lorazepam	Lorazepam
0093-3426	Lorazepam	Lorazepam
0093-3427	Lorazepam	Lorazepam
0121-0770	Lorazepam	Lorazepam